CHEK2 and glioblastoma: In our study, the expression levels of DNA damage related proteins like ATR, CHK2, p53, and H2AX were not significantly altered in GSCs following NXD30001 treatment combined with radiation, indicating that NXD30001 was able to enhance the radio-sensitivity of GBM by reduction of the DNA damage response after radiotherapy.